What Alignment Healthcare (ALHC) Said on Its Q3 Earnings Call

Alignment Healthcare NASDAQ: ALHC reported third-quarter revenue growth of 37% as membership rose 31% from a year earlier, but the Medicare Advantage insurer lowered its full-year profitability outlook after elevated medical costs, provider appeals and claims-processing volatility pressured results.

MarketBeat • 36 minutes ago

Alignment Healthcare Reports Third Quarter 2026 Results, Updates Full-Year Outlook

ORANGE, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today reported financial results for its third quarter ended Sept. 30, 2026.

GlobeNewsWire • 5 hours ago

Alignment Healthcare (ALHC) Reports Q3 Loss, Beats Revenue Estimates

Alignment Healthcare (ALHC) came out with a quarterly loss of $0.04 per share in line with the Zacks Consensus Estimate. This compares to earnings of $0.02 per share a year ago.

Zacks Investment Research • an hour ago

Here's What Key Metrics Tell Us About Alignment Healthcare (ALHC) Q3 Earnings

The headline numbers for Alignment Healthcare (ALHC) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks Investment Research • an hour ago

$ALHC Stock Market Alert: Alignment Healthcare Investigated for Securities Fraud after Inflated EBITDA Leads to 16% Stock Drop – Contact BFA Law if You Lost Money

NEW YORK, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Alignment Healthcare, Inc. (NASDAQ:ALHC) for potential securities fraud after its significant stock drop. If you invested in Alignment securities, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/alignment-class-action-lawsuit.

GlobeNewsWire • Oct 28, 2026

Allspring Emerging Growth Fund: Q3 2026 Top Contributors And Detractors

After delivering results well above expectations, TWST management significantly raised its outlook and projected triple-digit growth in orders. During the quarter, LIFE shares performed well following a strong earnings beat. During the quarter, several key approvals and coverage expansions supported product growth for GH.

Seeking Alpha • Oct 28, 2026

ALHC Investor Investigation: Alignment Healthcare Investors Are Alerted to the Securities Fraud Investigation after Inflated EBITDA Leads to 16% Stock Drop

BFA Law is investigating whether Alignment Healthcare, Inc. committed securities fraud relating to allegations that the company and its senior executives artificially inflated adjusted EBITDA to boost executive compensation. NEW YORK, Oct. 27, 2026 /PRNewswire/ -- Leading securities law firm Bleichmar Fonti & Auld LLP  announces an investigation into Alignment Healthcare, Inc. (NASDAQ:ALHC) for potential securities fraud after its significant stock drop.

PRNewsWire • Oct 27, 2026

$ALHC Stock Losses: BFA Law Reminds Alignment Healthcare Investors with Losses of the Ongoing Securities Fraud Investigation into Potential Inflated EBITDA Misrepresentations

BFA Law Reminds Alignment Healthcare Investors with Losses of the Ongoing Securities Fraud Investigation into Potential Inflated EBITDA Misrepresentations

GlobeNewsWire • Oct 26, 2026

ALHC Investigation News: Alignment Healthcare Investors are Notified of the Pending Securities Fraud Investigation – Contact BFA Law if You Lost Money

NEW YORK, Oct. 23, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces an investigation into Alignment Healthcare, Inc. (NASDAQ:ALHC) for potential securities fraud after its significant stock drop. If you invested in Alignment securities, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/alignment-class-action-lawsuit.

GlobeNewsWire • Oct 23, 2026

Analysts Estimate Alignment Healthcare (ALHC) to Report a Decline in Earnings: What to Look Out for

Alignment Healthcare (ALHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research • Oct 22, 2026